Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.
Frantz C, Huscher D, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Siegert E, Lazzaroni MG, Carreira PE, Vettori S, Zanatta E, Ullman S, Czirjàk L, Kowal-Bielecka O, Distler O, Matucci-Cerinic M, Allanore Y; EUSTAR co-authors. Frantz C, et al. Among authors: huscher d. Autoimmun Rev. 2020 Feb;19(2):102452. doi: 10.1016/j.autrev.2019.102452. Epub 2019 Dec 12. Autoimmun Rev. 2020. PMID: 31838157
Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
Rozman B, Cucnik S, Sodin-Semrl S, Czirják L, Varjú C, Distler O, Huscher D, Aringer M, Steiner G, Matucci-Cerinic M, Guiducci S, Stamenkovic B, Stankovic A, Kveder T. Rozman B, et al. Among authors: huscher d. Ann Rheum Dis. 2008 Sep;67(9):1282-6. doi: 10.1136/ard.2007.073981. Epub 2007 Dec 6. Ann Rheum Dis. 2008. PMID: 18063672
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.
Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G. Hanke K, et al. Among authors: huscher d. Arthritis Res Ther. 2009;11(1):R22. doi: 10.1186/ar2614. Epub 2009 Feb 16. Arthritis Res Ther. 2009. PMID: 19220911 Free PMC article.
Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort.
Hanke K, Dähnrich C, Brückner CS, Huscher D, Becker M, Jansen A, Meyer W, Egerer K, Hiepe F, Burmester GR, Schlumberger W, Riemekasten G. Hanke K, et al. Among authors: huscher d. Arthritis Res Ther. 2009;11(1):R28. doi: 10.1186/ar2622. Epub 2009 Feb 21. Arthritis Res Ther. 2009. PMID: 19232127 Free PMC article.
Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial.
Sporbeck B, Mathiske-Schmidt K, Jahr S, Huscher D, Becker M, Riemekasten G, Taufmann I, Burmester GR, Pögel S, Reisshauer A. Sporbeck B, et al. Among authors: huscher d. Rheumatol Int. 2012 May;32(5):1469-73. doi: 10.1007/s00296-011-1882-2. Epub 2011 Apr 8. Rheumatol Int. 2012. PMID: 21476099 Clinical Trial.
146 results